miRNA expression profiling for identification of potential breast cancer biomarkers

References

• Andorfer CA, Necela BM, Thompson EA, Perez EA. (2011). MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer. Trends Mol Med 17:313–319.
   PubMed Web of Science ®Google Scholar
• Baffa R, Fassan M, Volinia S, O’Hara B, Liu CG, Palazzo JP, Gardiman M, Rugge M, Gomella LG, Croce CM, Rosenberg A. (2009). MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 219:214–221.
   PubMed Web of Science ®Google Scholar
• Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, Barbosa-Morais NL, Teschendorff AE, Green AR, Ellis IO, Tavaré S, Caldas C, Miska EA. (2007). MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 8:R214.
   PubMed Web of Science ®Google Scholar
• Bonnomet A, Syne L, Brysse A, Feyereisen E, Thompson EW, Noël A, Foidart JM, Birembaut P, Polette M, Gilles C. (2011). A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer. Oncogene. [Epub ahead of print].
   Google Scholar
• Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT. (2009). The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611–622.
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. (2006). MicroRNA signatures in human cancers. Nat Rev Cancer 6:857–866.
   PubMed Web of Science ®Google Scholar
• Eccles SA, Welch DR. (2007). Metastasis: recent discoveries and novel treatment strategies. Lancet 369:1742–1757.
   PubMed Web of Science ®Google Scholar
• Esquela-Kerscher A, Slack FJ. (2006). Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6:259–269.
   PubMed Web of Science ®Google Scholar
• Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. (2008). The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10:593–601.
   PubMed Web of Science ®Google Scholar
• Heneghan HM, Miller N, Kerin MJ. (2011). Circulating microRNAs: promising breast cancer Biomarkers. Breast Cancer Res 13:402; author reply 403.
   Google Scholar
• Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ. (2010). Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251:499–505.
   PubMed Web of Science ®Google Scholar
• Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065–7070.
   PubMed Web of Science ®Google Scholar
• Jackson RJ, Standart N. (2007). How do microRNAs regulate gene expression? Sci STKE 2007:re1.
   PubMedGoogle Scholar
• Janssen EA, Slewa A, Gudlaugsson E, Jonsdottir K, Skaland I, Søiland H, Baak JP. (2010). Biologic profiling of lymph node negative breast cancers by means of microRNA expression. Mod Pathol 23:1567–1576.
   PubMed Web of Science ®Google Scholar
• Johnson ML, Navanukraw C, Grazul-Bilska AT, Reynolds LP, Redmer DA. (2003). Heparinase treatment of RNA before quantitative real-time RT-PCR. BioTechniques 35:1140–2, 1144.
   PubMed Web of Science ®Google Scholar
• Lowery AJ, Miller N, Devaney A, McNeill RE, Davoren PA, Lemetre C, Benes V, Schmidt S, Blake J, Ball G, Kerin MJ. (2009). MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res 11:R27.
   PubMed Web of Science ®Google Scholar
• Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. (2005). MicroRNA expression profiles classify human cancers. Nature 435:834–838.
   PubMed Web of Science ®Google Scholar
• Ma L, Teruya-Feldstein J, Weinberg RA. (2007). Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449:682–688.
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513–10518.
   PubMed Web of Science ®Google Scholar
• Mostert B, Sieuwerts AM, Martens JW, Sleijfer S. (2011). Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients. Expert Rev Mol Diagn 11:259–275.
   PubMed Web of Science ®Google Scholar
• Roth C, Rack B, Müller V, Janni W, Pantel K, Schwarzenbach H. (2010). Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res 12:R90.
   PubMed Web of Science ®Google Scholar
• Shammas FV, Van Eekelen JA, Wee L, Heikkilä R, Osland A. (1999). Sensitive and quantitative one-step polymerase chain reaction using capillary electrophoresis and fluorescence detection for measuring cytokeratin 19 expression. Scand J Clin Lab Invest 59:635–642.
   PubMed Web of Science ®Google Scholar
• Shi M, Liu D, Duan H, Shen B, Guo N. (2010). Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis. Cancer Metastasis Rev 29:785–799.
   Google Scholar
• Tjensvoll K, Gilje B, Oltedal S, Shammas VF, Kvaløy JT, Heikkilä R, Nordgård O. (2009). A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow. Breast Cancer Res Treat 116:329–338.
   Google Scholar
• Tjensvoll K, Oltedal S, Heikkilä R, Kvaløy JT, Gilje B, Reuben JM, Smaaland R, Nordgård O. Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome. BMC Cancer.
   Google Scholar
• Velu CS, Baktula AM, Grimes HL. (2009). Gfi1 regulates miR-21 and miR-196b to control myelopoiesis. Blood 113:4720–4728.
   PubMed Web of Science ®Google Scholar
• Wong L, Lee K, Russell I, Chen C. (2007). Endogenous controls for real-time quantitation of miRNA using TaqMan MicroRNA assays. Application Note, Applied Biosystems.
   Google Scholar
• Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S. (2010). A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS ONE 5:e13735.
   PubMed Web of Science ®Google Scholar